Brand profile · Biotechnology Research

Aperbio Technologies

Aperbio Technologies is a Biotechnology Research brand in Singapore. Ownership is privately held; it publishes at aperbio.com. It holds one address on record, all in Singapore. The record counts 8 people. One Singapore registration (UEN) is a confirmed match. It is listed alongside four similar brands, mostly in Biotechnology Research.

Profile live Privately Held Founded 2013 1 entity UEN 1 office country
Registry verified · ACRA

Key facts

Counted staff
8
self-reported band not used
Founded
2013
13 years
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

Legal entities

Aperbio Technologies: 1 registry entityAperbio Technologies is linked to 1 registry entity: APERBIO TECHNOLOGIES (SINGAPORE) PTE. LTD. (UEN 202432090E, confirmed).Aperbio TechnologiesAPERBIO TECHNOLOGIES(SINGAPORE) PTE. LTD.UEN 202432090EConfirmed · ACRA
Show as table · Aperbio Technologies: 1 registry entity
Aperbio Technologies: 1 registry entity
APERBIO TECHNOLOGIES (SINGAPORE) PTE. LTD.UEN 202432090E
Confirmed matches1 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Aperbio Technologies (Suzhou) Co., Ltd., founded in 2013, is a dedicated manufacturer and provider that combines innovation with cutting-edge advancements in intelligent instruments and diagnostic reagents. The company specializes in bridging the gap between life science research and clinical diagnostics, offering a wide range of products and solutions. Aperbio's expertise spans key areas such as oncology, infectious diseases, food safety, and cell and gene therapy.

Driven by the mission of "Precision for Life," Aperbio is committed to advancing global health through faster, more accurate, and highly precise diagnostic solutions. By delivering innovative tools and technologies, Aperbio aims to empower researchers and healthcare professionals to improve outcomes and transform lives.

For more information, visit https://www.aperbio.com

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary SG. Codes: SG.1 countryprimary SGSG
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countrySG

All codes: SG

Addresses

  • SGSingaporePrimary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

2 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Aperbio Technologies?

One Singapore entity on ACRA. APERBIO TECHNOLOGIES (SINGAPORE) PTE. LTD. (UEN 202432090E), high confidence.

How many people work at Aperbio Technologies?

The record holds 8 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.

Where does Aperbio Technologies have offices?

One address on record, Singapore only. Primary: Singapore.

Has Aperbio Technologies raised funding?

None linked to this brand.

Which companies are listed alongside Aperbio Technologies?

4 profiles list Aperbio Technologies as a peer — 56th percentile in Biotechnology Research. It lists ten peers of its own. Next Level Genomics Pte Ltd and IMMODX LLC list it back.